{"altmetric_id":16025553,"counts":{"readers":{"mendeley":7,"citeulike":0,"connotea":0},"total":{"posts_count":1},"policy":{"unique_users_count":1,"unique_users":["awmf"],"posts_count":1}},"citation":{"altmetric_jid":"4f6fa6143cf058f610007106","authors":["Rull, J A","Quibrera, R","Gonz\u00e1lez-Mill\u00e1n, H","Lozano Casta\u00f1eda, O"],"first_seen_on":"2017-02-01T15:06:41+00:00","issns":["0012-186X"],"issue":"4","journal":"Diabetologia","last_mentioned_on":1452124800,"links":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/4902717"],"pmid":"4902717","pubdate":"1969-08-01T00:00:00+00:00","publisher_subjects":[{"name":"Clinical Sciences","scheme":"era"},{"name":"Paediatrics And Reproductive Medicine","scheme":"era"},{"name":"Public Health And Health Services","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"subjects":["endocrinology"],"title":"Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol): double blind crossover trial.","type":"article","volume":"5","mendeley_url":"http:\/\/www.mendeley.com\/research\/symptomatic-treatment-peripheral-diabetic-neuropathy-carbamazepine-tegretol-double-blind-crossover-t"},"altmetric_score":{"score":3,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":3},"context_for_score":{"all":{"total_number_of_other_articles":7076830,"mean":6.2886729838999,"rank":1665184,"this_scored_higher_than_pct":64,"this_scored_higher_than":4568312,"rank_type":"exact","sample_size":7076830,"percentile":64},"similar_age_3m":{"total_number_of_other_articles":94202,"mean":11.203596543561,"rank":28810,"this_scored_higher_than_pct":67,"this_scored_higher_than":63798,"rank_type":"exact","sample_size":94202,"percentile":67},"this_journal":{"total_number_of_other_articles":1913,"mean":14.645487447699,"rank":689,"this_scored_higher_than_pct":49,"this_scored_higher_than":938,"rank_type":"exact","sample_size":1913,"percentile":49},"similar_age_this_journal_3m":{"total_number_of_other_articles":21,"mean":52.3515,"rank":11,"this_scored_higher_than_pct":47,"this_scored_higher_than":10,"rank_type":"exact","sample_size":21,"percentile":47}}},"demographics":{"users":{"mendeley":{"by_status":{"Professor > Associate Professor":2,"Student  > Doctoral Student":1,"Student  > Postgraduate":1,"Other":2,"Student  > Master":1},"by_discipline":{"Medicine and Dentistry":5,"Biochemistry, Genetics and Molecular Biology":1,"Unspecified":1}}},"geo":{"mendeley":{"CO":1}}},"posts":{"policy":[{"title":"Nationale VersorgungsLeitlinie Neuropathie bei Diabetes im Erwachsenenalter: Evidenztabellen","url":"http:\/\/www.awmf.org\/fileadmin\/user_upload\/Leitlinien\/Nationale_Versorgungs-Leitlinie\/nvl-001e_E_S3_Diabetes_Neuropathie_2013-12.pdf","license":"public","citation_ids":[3168112,3176592,16025548,1529015,16025552,512629,16025553,16025554,16025555,16025557,1721038,2431796,16025558,2431881,16025560,16025561,1167614,16025564,16025565,16025566,16025568,16025569,16025570,16025572,8137398,8137396,211622,4121964,2214551,3180134,1906404,3196703,1873640,1814753],"posted_on":"2016-01-07T00:00:00+00:00","source":{"name":"The Association of the Scientific Medical Societies in Germany","description":"The Association of the Scientific Medical Societies in Germany (AWMF) is an umbrella organization of over 150 societies, and advises the government of the Federal Republic of Germany as well as the governments of the German federal countries in all topics of scientific medicine and medical research and classification.","geo":{"country":"DE"}},"page_url":"http:\/\/www.awmf.org\/leitlinien\/detail\/ll\/nvl-001e.html","collections":[],"author":{"image":"https:\/\/s3.amazonaws.com\/cache.altmetric.com\/policy\/thumbnails\/thumbnail-82af1b41388efc3ea0ee3127935b58d270f21b37f958ed946d3751a7a9418ddb.jpg"}}]}}